A phase I dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly and twice weekly erlotinib in advanced stage solid malignancies

被引：0
|
作者：
Chia, S. K.
Chi, K. N.
Kollmannsberger, C.
Paton, K.
Bhagat, K.
D'Aloisio, S.
Das-Gupta, A.
Kletzl, H.
Zwanziger, E.
Gelmon, K.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC, Canada
[2] Vancouver Gen Hosp, Vancouver, BC, Canada
[3] F Hoffmann La Roche, Basel, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3594
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
    Reece, Donna E.
    Sanchorawala, Vaishali
    Hegenbart, Ute
    Merlini, Giampaolo
    Palladini, Giovanni
    Fermand, Jean-Paul
    Vescio, Robert A.
    Liu, Xiangyang
    Elsayed, Yusri A.
    Cakana, Andrew
    Comenzo, Raymond L.
    BLOOD, 2009, 114 (08) : 1489 - 1497
  • [32] Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of intravenous dimethane sulfonate (DMS612, NSC 281612) in advanced malignancies
    Bates, Susan Elaine
    Balasubramaniam, Sanjeeve
    Parise, Robert A.
    Bryla, Christina
    Bonner, William
    Redon, Christophe E.
    Nakamura, Asako
    Wright, John Joseph
    Piekarz, Richard
    Jiang, Yixing
    Eiseman, Julie
    Chu, Edward
    Belani, Chandra Prakash
    Beumer, Jan Hendrik
    Appleman, Leonard Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] A phase I pharmacokinetic study of a liposomal formulation of paclitaxel administered weekly to Asian patients with solid malignancies
    Lim, W. T.
    Leong, S. S.
    Toh, C. K.
    Ang, C. S.
    Wong, N. S.
    Tan, E. H.
    Chowbay, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Phase I and pharmacokinetic study of irofulven administered weekly or biweekly in advanced solid tumor patients
    Alexandre, J
    Raymond, E
    Kaci, MO
    Brain, EC
    Lokiec, FO
    Kahatt, C
    Faivre, S
    Yovine, A
    Goldwasser, FO
    Smith, SL
    MacDonald, JR
    Misset, JL
    Cvitkovic, E
    CLINICAL CANCER RESEARCH, 2004, 10 (10) : 3377 - 3385
  • [35] A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors
    Montero, Alberto J.
    Kwon, Deukwoo
    Flores, Aurea
    Kovacs, Krisztina
    Trent, Jonathan C.
    Benedetto, Pasquale
    Rocha-Lima, Caio
    Merchan, Jaime R.
    CLINICAL CANCER RESEARCH, 2016, 22 (13) : 3209 - 3217
  • [36] Weekly paclitaxel in combination with carboplatin: A phase I study in advanced malignancies
    Belani, CP
    Ramanathan, RK
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 63 - 63
  • [37] A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEGinterferon alpha-2b in patients with refractory or advanced solid tumours
    Coker, Shodeinde A.
    Dandamudi, Uday B.
    Beelen, Andrew P.
    Crosby, Nancy A.
    Fisher, Jan L.
    Obrocea, Michael
    Ernstoff, Marc S.
    Lewis, Lionel D.
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (06) : 362 - 368
  • [38] A Phase I Dose-escalation, Pharmacokinetic (PK) and Pharmacodynamic (PD) Evaluation of LY2940680, an Oral Smo Inhibitor
    Bendell, J.
    Weiss, G.
    Infante, J.
    Ramanathan, R.
    Jones, S.
    Korn, R.
    Burns, H.
    Brail, L.
    Jones, E.
    Von Hoff, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 182 - 182
  • [39] A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors
    Voortman, Jens
    Smit, Egbert F.
    Honeywell, Richard
    Kuenen, Bart C.
    Peters, Godefridus J.
    de Velde, Helgi van
    Giaccone, Giuseppe
    CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3642 - 3651
  • [40] Phase I study of weekly irinotecan combined with weekly cisplatin in patients with advanced solid tumors
    Nakanishi, Y
    Takayama, K
    Wataya, H
    Izumi, M
    Minami, T
    Takano, K
    Inoue, K
    Osaki, S
    Kimotsuki, K
    Harada, T
    Hara, N
    CHEMOTHERAPY, 2002, 48 (04) : 205 - 210
12345